EARNINGS: CRISM, Ampeak and Ethtry widen 2025 pretax loss
(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Friday and not separately reported by Alliance News: Read More
| Price | 9.50p on 31-07-2026 at 18:15:04 |
|---|---|
| Change | 0.00p 0% |
| Buy | 10.00p |
| Sell | 9.00p |
| Last Trade: | Buy 883.00 at 9.90p |
| Day's Volume: | 6,863 |
| Last Close: | 9.50p |
| Open: | 9.50p |
| ISIN: | VGG042401262 |
| Day's Range | 9.50p - 9.50p |
| 52wk Range: | 8.25p - 18.25p |
| Market Capitalisation: | £7.52m |
| VWAP: | 9.818802p |
| Shares in Issue: | 79.19m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Crism Thera (CRTX) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 883 | 9.90p | Suspected BUY Trade |
16:08:32 - 31-Jul-26 |
| Buy* | 914 | 9.90p | Suspected BUY Trade |
16:02:19 - 31-Jul-26 |
| Buy* | 5,066 | 9.79p | Ordinary |
15:37:23 - 31-Jul-26 |
| Buy* | 10,000 | 9.84p | Ordinary |
16:22:58 - 30-Jul-26 |
| Buy* | 40 | 9.522p | Ordinary |
16:06:01 - 30-Jul-26 |
| Buy* | 3,109 | 9.522p | Ordinary |
15:16:28 - 30-Jul-26 |
| Sell* | 223 | 9.17p | Ordinary |
14:36:30 - 30-Jul-26 |
| Buy* | 1,326 | 9.84p | Ordinary |
14:34:01 - 30-Jul-26 |
| Sell* | 10 | 9.00p | Ordinary |
12:38:25 - 30-Jul-26 |
| Unknown* | 200,000 | 9.155p | Negotiated Trade |
08:28:13 - 30-Jul-26 |
Crism Thera (CRTX) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 29th Jul 2026 4:02 pm | RNS | Holding(s) in Company |
| 27th Jul 2026 7:00 am | RNS | Result of Shareholder Analysis |
| 2nd Jul 2026 4:31 pm | RNS | Holding(s) in Company |
| 30th Jun 2026 3:30 pm | RNS | Grant of Options |
| 26th Jun 2026 7:00 am | RNS | FINAL RESULTS |
| 25th Jun 2026 7:00 am | RNS | Phase 2 Clinical Trial Progress Update |
| 22nd Jun 2026 8:49 am | RNS | Holding(s) in Company |
| 16th Jun 2026 5:13 pm | RNS | Holding(s) in Company |
| 15th Jun 2026 11:15 am | RNS | Result of General Meeting |
| 4th Jun 2026 7:00 am | RNS | Significant Grant Award |